Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model.
Le Béchec A, Portales-Casamar E, Vetter G, Moes M, Zindy PJ, Saumet A, Arenillas D, Theillet C, Wasserman WW, Lecellier CH, Friederich E. Le Béchec A, et al. Among authors: theillet c. BMC Bioinformatics. 2011 Mar 4;12:67. doi: 10.1186/1471-2105-12-67. BMC Bioinformatics. 2011. PMID: 21375730 Free PMC article.
miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.
Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E. Vetter G, et al. Among authors: theillet c. Oncogene. 2010 Aug 5;29(31):4436-48. doi: 10.1038/onc.2010.181. Epub 2010 Jun 14. Oncogene. 2010. Retraction in: Oncogene. 2016 Feb 11;35(6):670. doi: 10.1038/onc.2015.265 PMID: 20543867 Free PMC article. Retracted.
Retraction: miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.
Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E. Vetter G, et al. Among authors: theillet c. Oncogene. 2016 Feb 11;35(6):670. doi: 10.1038/onc.2015.265. Epub 2015 Dec 14. Oncogene. 2016. PMID: 32667144 Free PMC article.
Prognostic significance of TRIM24/TIF-1α gene expression in breast cancer.
Chambon M, Orsetti B, Berthe ML, Bascoul-Mollevi C, Rodriguez C, Duong V, Gleizes M, Thénot S, Bibeau F, Theillet C, Cavaillès V. Chambon M, et al. Among authors: theillet c. Am J Pathol. 2011 Apr;178(4):1461-9. doi: 10.1016/j.ajpath.2010.12.026. Am J Pathol. 2011. PMID: 21435435 Free PMC article.
Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
Bach AS, Derocq D, Laurent-Matha V, Montcourrier P, Sebti S, Orsetti B, Theillet C, Gongora C, Pattingre S, Ibing E, Roger P, Linares LK, Reinheckel T, Meurice G, Kaiser FJ, Gespach C, Liaudet-Coopman E. Bach AS, et al. Among authors: theillet c. Oncotarget. 2015 Sep 29;6(29):28084-103. doi: 10.18632/oncotarget.4394. Oncotarget. 2015. PMID: 26183398 Free PMC article.
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.
Bonnet F, Guedj M, Jones N, Sfar S, Brouste V, Elarouci N, Banneau G, Orsetti B, Primois C, de Lara CT, Debled M, de Mascarel I, Theillet C, Sévenet N, de Reynies A, MacGrogan G, Longy M. Bonnet F, et al. Among authors: theillet c. BMC Med Genomics. 2012 Nov 27;5:54. doi: 10.1186/1755-8794-5-54. BMC Med Genomics. 2012. PMID: 23186559 Free PMC article.
144 results